Hamps Bio Limited
Incorporated in 2007, Hamps Bio Ltd is in the business of Pharmaceutical Formulation and Freeze-Drying Ingredient Manufacturing and Distribution[1]
- Market Cap ₹ 21.2 Cr.
- Current Price ₹ 24.3
- High / Low ₹ 35.0 / 13.4
- Stock P/E
- Book Value ₹ 9.30
- Dividend Yield 0.00 %
- ROCE -33.7 %
- ROE -87.5 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 2.61 times its book value
- Company has low interest coverage ratio.
- Earnings include an other income of Rs.3.32 Cr.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 66.69 | 84.75 | |
| 58.99 | 84.41 | |
| Operating Profit | 7.70 | 0.34 |
| OPM % | 11.55% | 0.40% |
| 1.51 | 3.32 | |
| Interest | 1.40 | 2.49 |
| Depreciation | 3.77 | 8.17 |
| Profit before tax | 4.04 | -7.00 |
| Tax % | 26.49% | 5.57% |
| 2.98 | -7.39 | |
| EPS in Rs | 3.43 | -8.48 |
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -348% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | -87% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 4.36 | 8.71 |
| Reserves | 4.44 | -0.61 |
| 2.97 | 6.88 | |
| 1.02 | 0.94 | |
| Total Liabilities | 12.79 | 15.92 |
| 2.59 | 9.10 | |
| CWIP | 3.28 | 1.08 |
| Investments | 0.00 | 0.07 |
| 6.92 | 5.67 | |
| Total Assets | 12.79 | 15.92 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| -1.77 | 1.52 | |
| -6.21 | -2.86 | |
| 8.00 | 3.72 | |
| Net Cash Flow | 0.03 | 2.38 |
| Free Cash Flow | -5.49 | -3.61 |
| CFO/OP | -24% | 447% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 6.51 | 6.85 |
| Inventory Days | 43.46 | 29.75 |
| Days Payable | 10.96 | 3.92 |
| Cash Conversion Cycle | 39.01 | 32.68 |
| Working Capital Days | 12.42 | 6.50 |
| ROCE % | -33.72% |
Insights
In beta| Mar 2025 | |
|---|---|
| FMCG Division SKU Count (FZYZEY brand) SKUs (freeze-dried products) |
|
| Pharma Division Product Count items (dosage forms) |
|
| Solar Power Plant Capacity (Ankleshwar Unit) kVA |
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
14 Jul - Certificate under Reg. 74 (5) of SEBI (DP) Regulation, 2018 for the quarter ended 30th June 2026.
-
Intimation-Under-Regulation-30(5)-Of-The-SEBI-LODR
6 Jul - Hamps Bio disclosed KMPs authorized for materiality decisions and stock exchange disclosures, effective July 6, 2026.
-
Appointment of Company Secretary and Compliance Officer
6 Jul - Board approved Komal Jain’s resignation and appointed Ravi Baheti as Company Secretary from July 6, 2026.
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
6 Jul - Board approved CS resignation, appointed Ravi Baheti, and authorized KMPs on 06 Jul 2026.
-
Board Meeting Outcome for Outcome Of Board Meeting Dated 06.07.2026 Is Attached Herewith.
6 Jul - Komal Jain resigned; Ravi Baheti appointed Company Secretary and Compliance Officer effective 6 July 2026.
Business Overview:[1]
HBL is in the business of ethical marketing and distribution of pharmaceutical formulations across wide range of dosage including tablets, syrups, capsules, injectables, oil, gel and powder used as medicine & nutrition supplements as well as the manufacturing of freeze dried and frozen products such as fruits, vegetables, herbs and flowers.